2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid

C92H114N16O20S — CID 134213414

IUPAC2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@H]2Cc3ccc(O)cc3N(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N(C)[C@@H](Cc3ccccc3)C(=O)N1C)C2=O
InChIInChI=1S/C92H114N16O20S/c1-10-11-26-72-90(126)104(6)48-77(113)97-68(45-80(116)117)86(122)103-81(53(4)5)92(128)106(8)74(40-54-20-14-12-15-21-54)87(123)101-70-42-58-31-36-62(111)44-73(58)108(89(70)125)49-78(114)96-67(43-59-46-94-64-25-19-18-24-63(59)64)85(121)100-66(38-56-27-32-60(109)33-28-56)84(120)99-65(37-52(2)3)83(119)102-71(82(118)95-47-76(93)112)50-129-51-79(115)98-69(39-57-29-34-61(110)35-30-57)88(124)107(9)75(91(127)105(72)7)41-55-22-16-13-17-23-55/h12-25,27-36,44,46,52-53,65-72,74-75,81,94,109-111H,10-11,26,37-43,45,47-51H2,1-9H3,(H2,93,112)(H,95,118)(H,96,114)(H,97,113)(H,98,115)(H,99,120)(H,100,121)(H,101,123)(H,102,119)(H,103,122)(H,116,117)/t65-,66-,67-,68-,69-,70-,71-,72-,74-,75-,81-/m0/s1
InChIKeyRKLXKGRPUKFKBG-GZGMTWSWSA-N
MW1796.08 g/mol
LogP1.92
Rot. Bonds21

About 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid

2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid (PubChem CID 134213414) has the molecular formula C92H114N16O20S and a molecular weight of 1796.08 g/mol. Its IUPAC name is 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid.

Molecular Properties

Compound Name2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid
PubChem CID134213414
Molecular FormulaC92H114N16O20S
Molecular Weight1796.08 g/mol
Exact Mass1794.81
IUPAC Name2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid
SMILESCCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@H]2Cc3ccc(O)cc3N(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N(C)[C@@H](Cc3ccccc3)C(=O)N1C)C2=O
InChIInChI=1S/C92H114N16O20S/c1-10-11-26-72-90(126)104(6)48-77(113)97-68(45-80(116)117)86(122)103-81(53(4)5)92(128)106(8)74(40-54-20-14-12-15-21-54)87(123)101-70-42-58-31-36-62(111)44-73(58)108(89(70)125)49-78(114)96-67(43-59-46-94-64-25-19-18-24-63(59)64)85(121)100-66(38-56-27-32-60(109)33-28-56)84(120)99-65(37-52(2)3)83(119)102-71(82(118)95-47-76(93)112)50-129-51-79(115)98-69(39-57-29-34-61(110)35-30-57)88(124)107(9)75(91(127)105(72)7)41-55-22-16-13-17-23-55/h12-25,27-36,44,46,52-53,65-72,74-75,81,94,109-111H,10-11,26,37-43,45,47-51H2,1-9H3,(H2,93,112)(H,95,118)(H,96,114)(H,97,113)(H,98,115)(H,99,120)(H,100,121)(H,101,123)(H,102,119)(H,103,122)(H,116,117)/t65-,66-,67-,68-,69-,70-,71-,72-,74-,75-,81-/m0/s1
InChIKeyRKLXKGRPUKFKBG-GZGMTWSWSA-N
XLogP1.92
TPSA520.32 Ų
H-Bond Donors15
H-Bond Acceptors20
Rotatable Bonds21
Heavy Atoms129
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001796.08
LogP ≤ 51.92
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1020

Analyze 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid?
The IUPAC name of 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid (CID 134213414) is 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid.
What is the SMILES notation for 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid?
The canonical SMILES for 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid is CCCC[C@H]1C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](Cc2ccccc2)C(=O)N[C@H]2Cc3ccc(O)cc3N(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N(C)[C@@H](Cc3ccccc3)C(=O)N1C)C2=O.
What is the InChIKey of 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid?
The InChIKey is RKLXKGRPUKFKBG-GZGMTWSWSA-N. The full InChI is InChI=1S/C92H114N16O20S/c1-10-11-26-72-90(126)104(6)48-77(113)97-68(45-80(116)117)86(122)103-81(53(4)5)92(128)106(8)74(40-54-20-14-12-15-21-54)87(123)101-70-42-58-31-36-62(111)44-73(58)108(89(70)125)49-78(114)96-67(43-59-46-94-64-25-19-18-24-63(59)64)85(121)100-66(38-56-27-32-60(109)33-28-56)84(120)99-65(37-52(2)3)83(119)102-71(82(118)95-47-76(93)112)50-129-51-79(115)98-69(39-57-29-34-61(110)35-30-57)88(124)107(9)75(91(127)105(72)7)41-55-22-16-13-17-23-55/h12-25,27-36,44,46,52-53,65-72,74-75,81,94,109-111H,10-11,26,37-43,45,47-51H2,1-9H3,(H2,93,112)(H,95,118)(H,96,114)(H,97,113)(H,98,115)(H,99,120)(H,100,121)(H,101,123)(H,102,119)(H,103,122)(H,116,117)/t65-,66-,67-,68-,69-,70-,71-,72-,74-,75-,81-/m0/s1.
What are the key properties of 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid?
2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid has a molecular weight of 1796.08 g/mol, XLogP of 1.92, 21 rotatable bonds, 15 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1S,4S,7S,10S,16S,19S,22S,28R,31S,34S,37S)-28-[(2-amino-2-oxoethyl)carbamoyl]-4,19-dibenzyl-16-butyl-44-hydroxy-22,34-bis[(4-hydroxyphenyl)methyl]-37-(1H-indol-3-ylmethyl)-5,14,17,20-tetramethyl-31-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36,39,49-tridecaoxo-7-propan-2-yl-26-thia-2,5,8,11,14,17,20,23,29,32,35,38,41-tridecazatricyclo[39.7.1.042,47]nonatetraconta-42(47),43,45-trien-10-yl]acetic acid is sourced from PubChem (CID 134213414), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).